Elevation of serum TNF-α levels in mild and moderate Alzheimer patients with daytime sleepiness

Journal of Neuroimmunology

Volumn 244, Issue 1-2, 2012, Pages 97-102

  Chen, Rui ^a   Yin, You ^a   Zhao, Zhongxin ^a   Huang, Liuqing ^a   Huang, Shuqi ^a   Zhuang, Jianhua ^a   Wu, Huijuan ^a   Peng, Hua ^a   Li, Peng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer disease; IL 1 ; Sleepiness; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SLEEP WAKING CYCLE; SLOW WAVE SLEEP;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862786623     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.12.015     Document Type: Article

References (30)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
2. Bedrosian T.A., Herring K.L., Weil Z.M., Nelson R.J. Altered temporal patterns of anxiety in aged and amyloid precursor protein (APP) transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:11686-11691.
3. Bonanni E., Maestri M., Tognoni G., Fabbrini M., Nucciarone B., Manca M.L., Gori S., Iudice A., Murri L. Daytime sleepiness in mild and moderate Alzheimer's disease and its relationship with cognitive impairment. J. Sleep Res. 2005, 14:311-317.
4. Bonotis K., Krikki E., Holeva V., Aggouridaki C., Costa V., Baloyannis S. Systemic immune aberrations in Alzheimer's disease patients. J. Neuroimmunol. 2008, 193:183-187.
5. Bredow S., Guha-Thakurta N., Taishi P., Obal F., Krueger J.M. Diurnal variations of tumor necrosis factor alpha mRNA and alpha-tubulin mRNA in rat brain. Neuroimmunomodulation 1997, 4:84-90.
6. Chen N.H., Johns M.W., Li H.Y., Chu C.C., Liang S.C., Shu Y.H., Chuang M.L., Wang P.C. Validation of a Chinese version of the Epworth sleepiness scale. Qual. Life Res. 2002, 11:817-821.
7. Fang J., Wang Y., Krueger J.M. Mice lacking the TNF 55 kDa receptor fail to sleep more after TNFalpha treatment. J. Neurosci. 1997, 17:5949-5955.
8. Fang J., Wang Y., Krueger J.M. Effects of interleukin-1 beta on sleep are mediated by the type I receptor. Am. J. Physiol. 1998, 274:R655-R660.
9. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
10. Griffin W.S., Mrak R.E. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J. Leukoc. Biol. 2002, 72:233-238.
11. in t' Veld B.A., Ruitenberg A., Hofman A., Launer L.J., van Duijn C.M., Stijnen T., Breteler M.M., Stricker B.H. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 2001, 345:1515-1521.
12. Klaffke S., Staedt J. Sundowning and circadian rhythm disorders in dementia. Acta Neurol. Belg. 2006, 106:168-175.
13. Krueger J.M., Walter J., Dinarello C.A., Wolff S.M., Chedid L. Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am. J. Physiol. 1984, 246:R994-R999.
14. Kubota T., Li N., Guan Z., Brown R.A., Krueger J.M. Intrapreoptic microinjection of TNF-alpha enhances non-REM sleep in rats. Brain Res. 2002, 932:37-44.
15. Kundermann B., Thum A., Rocamora R., Haag A., Krieg J.C., Hemmeter U. Comparison of polysomnographic variables and their relationship to cognitive impairment in patients with Alzheimer's disease and frontotemporal dementia. J. Psychiatr. Res. 2011.
16. Licastro F., Pedrini S., Ferri C., Casadei V., Govoni M., Pession A., Sciacca F.L., Veglia F., Annoni G., Bonafe M., Olivieri F., Franceschi C., Grimaldi L.M. Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann. Neurol. 2000, 48:388-391.
17. Lombardi V.R., Garcia M., Rey L., Cacabelos R. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals. J. Neuroimmunol. 1999, 97:163-171.
18. Lu C.Y., Yi P.L., Tsai C.H., Cheng C.H., Chang H.H., Hsiao Y.T., Chang F.C. TNF-NF-kappaB signaling mediates excessive somnolence in hemiparkinsonian rats. Behav. Brain Res. 2010, 208:484-496.
19. McCurry S.M., Logsdon R.G., Teri L., Gibbons L.E., Kukull W.A., Bowen J.D., McCormick W.C., Larson E.B. Characteristics of sleep disturbance in community-dwelling Alzheimer's disease patients. J. Geriatr. Psychiatry Neurol. 1999, 12:53-59.
20. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 1995, 21:195-218.
21. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
22. Moe K.E., Vitiello M.V., Larsen L.H., Prinz P.N. Symposium. Cognitive processes and sleep disturbances: sleep/wake patterns in Alzheimer's disease: relationships with cognition and function. J. Sleep Res. 1995, 4:15-20.
23. Opp M.R. Cytokines and sleep. Sleep Med. Rev. 2005, 9:355-364.
24. Prinz P.N., Vitaliano P.P., Vitiello M.V., Bokan J., Raskind M., Peskind E., Gerber C. Sleep, EEG and mental function changes in senile dementia of the Alzheimer's type. Neurobiol. Aging 1982, 3:361-370.
25. Rao M.N., Blackwell T., Redline S., Stefanick M.L., Ancoli-Israel S., Stone K.L. Association between sleep architecture and measures of body composition. Sleep 2009, 32:483-490.
26. Redline S., Kirchner H.L., Quan S.F., Gottlieb D.J., Kapur V., Newman A. The effects of age, sex, ethnicity, and sleep-disordered breathing on sleep architecture. Arch. Intern. Med. 2004, 164:406-418.
27. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Kales A., Tyson K., Chrousos G.P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab. 1997, 82:1313-1316.
28. Vgontzas A.N., Zoumakis E., Lin H.M., Bixler E.O., Trakada G., Chrousos G.P. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J. Clin. Endocrinol. Metab. 2004, 89:4409-4413.
29. Yang L., Lu R., Jiang L., Liu Z., Peng Y. Expression and genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A polymorphism in sporadic Alzheimer's disease in a Southern China population. Brain Res. 2009, 1247:178-181.
30. Zamarron C., Maceiras F., Mera A., Gomez-Reino J.J. Effect of the first infliximab infusion on sleep and alertness in patients with active rheumatoid arthritis. Ann. Rheum. Dis. 2004, 63:88-90.